Importantly, abnormal tau has recently been found to potentiate the toxic environment by interfering with the insulin signaling cascade in the brains of patients with AD (El Idrissi and Alonso, 2022), highlighting the deleterious consequences of tau pathology-induced insulin resistance in the brain (Gonçalves et al., 2019). Here, MAPT is linked to Alzheimer disease.